Streetbeat News

Price Targets

INTU

Oppenheimer analyst Scott Schneeberger has maintained an Outperform rating on Intuit (NASDAQ:INTU) and increased the price target from $610 to $678, indicating a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:45 pm

CRBP

Oppenheimer analyst Jeff Jones has maintained an Outperform rating on Corbus Pharmaceuticals (NASDAQ:CRBP) and increased the price target from $20 to $51, indicating a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:41 pm

AXP

Oppenheimer analyst Dominick Gabriele has maintained an Outperform rating on American Express (NYSE:AXP) and increased the price target from $208 to $219.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:39 pm

META

Jefferies analyst Brent Thill has maintained a Buy rating on Meta Platforms (NASDAQ:META) and increased the price target from $425 to $455.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:34 pm

AMD

Cantor Fitzgerald analyst C J Muse has reiterated an Overweight rating on Advanced Micro Devices (NASDAQ:AMD) and maintained a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:31 pm

ADI

Cantor Fitzgerald analyst C J Muse has reiterated a Neutral rating on Analog Devices (NASDAQ:ADI) and maintained a price target of $205.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:21 pm

NSC

Barclays analyst Brandon Oglenski has maintained an Equal-Weight rating on Norfolk Southern (NYSE:NSC) but reduced the price target from $240 to $235.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:13 pm

SRPT

Needham analyst Gil Blum has reiterated a Buy rating on Sarepta Therapeutics (NASDAQ:SRPT) and maintained a price target of $140.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:11 pm

JAZZ

Barclays analyst Balaji Prasad has maintained an Overweight rating on Jazz Pharmaceuticals (NASDAQ:JAZZ) but reduced the price target from $240 to $235.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:10 pm

ACHR

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on Archer Aviation (NYSE:ACHR) and maintained a $10 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:09 pm